Menu

John Clendenin

Partner

Working in the heart of Silicon Valley, I’ve been able to collaborate with some of the most successful investment firms in the world.

jclendenin@cooley.com

John's practice focuses on the representation of domestic and international investment funds, including venture capital, private equity, fund-of-funds, secondary funds and special opportunity funds in connection with their formation, operation and investment activities. He has represented sponsor organizations in the formation of over 50 fund programs, ranging from some of the most well-known multi-billion dollar investment firms to much smaller firms forming seed and early-stage venture capital, angel and similar microcap funds.  In addition to his fund formation practice, John also represents a number of emerging growth companies in financing transactions and general corporate matters. 

Download full bio 

Experience

  • Amplify Partners Announces Two New Funds Totaling $700 Million 

  • Obvious Ventures Raises Two New Funds Totaling $461 Million 

  • Infinity Ventures Launches Inaugural $158 Million Fund 

  • YL Ventures Closes Fifth Fund at $400 Million 

  • Slow Ventures Announces $325 Million in New Capital Across Two Funds 

  • View all

John is excellent to work with as he is incredibly responsive, thoughtful and able to synthesize issues in a way that is practical. He knows our fund structures and risk profile well. He is unfailingly client-oriented, highly responsive and great at managing his internal resources. – Chambers USA
Education

  • University of California at Davis King Hall School of Law
    JD, 2005

  • University of California, Davis
    MBA, Beta Gamma Sigma, 2005

  • University of Washington
    BA, magna cum laude, 2001


Admissions & Credentials

California

Rankings & Accolades

    Chambers: Investment Funds: Venture Capital: Fund Formation, California and USA - Nationwide (2020 – 2022)

    The Legal 500: Investment Fund Formation and Management – Private Equity Funds (including Venture Capital) (2020-2022)